Overview

A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations

Status:
RECRUITING

Trial end date:
2026-04-06

Target enrollment:

Participant gender:

Summary

A dose range-finding study to assess the efficacy and safety of multiple dose levels of AZD8630 administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, receiving medium -to -high dose inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA).

Phase:

PHASE2

Details

Lead Sponsor:

AstraZeneca

Treatments:

Nebulizers and Vaporizers